Insider filing · CGON

Brian Guan-Chyun Liu bought $24.8M of CG Oncology (CGON)

Executed Jun 25, disclosed Jun 29, 4 days later.

Over the 21 trading sessions from the disclosed entry session (Jun 29), the stock returned +3.3% (delay-adjusted); from the execution session (Jun 25), +8.0%. Derived: entry at the session's open, exit at the close 20 sessions later.

BL Brian Guan-Chyun Liu Director profile →

Brian Guan-Chyun Liu (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in CG Oncology, Inc. (CGON). Across 1 priced purchase filing, the average 21-session return was +8.0% from execution and +3.3% from disclosure (delay-adjusted; derived). The largest single filing was $24.8M of CGON (371,085 sh × $66.87, as filed), executed Jun 25.

CGON CG Oncology, Inc. CGON · Healthcare · 14 filings in 24 months ticker →

Healthcare · CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→